Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ruud Dings

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
25
2022
187
4.150
Why?
Proteins
17
2010
342
2.510
Why?
Neovascularization, Pathologic
17
2022
161
2.470
Why?
Calixarenes
7
2017
9
2.020
Why?
Galectin 1
8
2024
21
1.880
Why?
Melanoma, Experimental
6
2021
45
1.880
Why?
Antineoplastic Agents
14
2024
1171
1.620
Why?
Peptides
20
2017
223
1.420
Why?
Mice
47
2024
5739
1.310
Why?
Neoplasms
14
2024
1235
1.250
Why?
Endothelial Cells
10
2022
269
1.070
Why?
Animals
53
2024
13187
1.070
Why?
Lung Neoplasms
5
2024
606
1.070
Why?
Ovarian Neoplasms
8
2008
447
0.900
Why?
Gold
7
2023
136
0.900
Why?
Oxygen
6
2020
326
0.880
Why?
Cell Line, Tumor
18
2024
1403
0.830
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
154
0.800
Why?
Carcinoma, Squamous Cell
4
2019
318
0.780
Why?
Proto-Oncogene Proteins c-met
1
2021
20
0.760
Why?
Peptide Fragments
5
2013
215
0.740
Why?
Mammary Neoplasms, Experimental
6
2015
122
0.730
Why?
Radiation-Sensitizing Agents
4
2023
53
0.730
Why?
Head and Neck Neoplasms
3
2019
268
0.720
Why?
Carcinoma, Lewis Lung
1
2019
10
0.690
Why?
Molecular Targeted Therapy
2
2018
119
0.680
Why?
Protein Kinase Inhibitors
1
2021
204
0.660
Why?
Preservation, Biological
1
2018
9
0.660
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
78
0.650
Why?
Anti-Bacterial Agents
4
2019
744
0.650
Why?
CD8-Positive T-Lymphocytes
1
2019
116
0.640
Why?
Radiation Tolerance
5
2020
85
0.640
Why?
Galectins
1
2018
5
0.630
Why?
Metal Nanoparticles
4
2023
84
0.580
Why?
Hyperthermia, Induced
3
2019
117
0.570
Why?
Bacteria
1
2018
224
0.570
Why?
Mice, Nude
12
2019
252
0.560
Why?
Radiotherapy
5
2021
128
0.550
Why?
Xenograft Model Antitumor Assays
11
2020
211
0.530
Why?
Pseudomonas aeruginosa
2
2013
72
0.500
Why?
Combined Modality Therapy
11
2020
637
0.450
Why?
Benzofurans
2
2012
18
0.440
Why?
Cytotoxins
1
2013
16
0.440
Why?
Pseudomonas Infections
1
2013
48
0.430
Why?
Cell Proliferation
10
2024
1007
0.430
Why?
Oxidation-Reduction
3
2024
322
0.430
Why?
Drug Design
4
2014
120
0.420
Why?
Endothelium, Vascular
8
2010
252
0.420
Why?
Carbohydrate Metabolism
1
2012
26
0.420
Why?
Humans
44
2024
49974
0.410
Why?
Benzeneacetamides
2
2024
13
0.410
Why?
Glutaminase
2
2024
19
0.400
Why?
Neoplasms, Experimental
4
2020
114
0.400
Why?
Nanostructures
3
2023
47
0.400
Why?
Bacteremia
1
2013
90
0.400
Why?
Sesquiterpenes
3
2010
90
0.390
Why?
Angiostatic Proteins
1
2011
1
0.380
Why?
Immunity, Cellular
1
2011
69
0.370
Why?
Molecular Mimicry
2
2007
38
0.370
Why?
Cell Survival
8
2024
600
0.360
Why?
Dendritic Cells
3
2021
133
0.360
Why?
Endothelium
4
2022
39
0.350
Why?
Carboplatin
3
2024
53
0.350
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
989
0.340
Why?
Tumor Necrosis Factor-alpha
4
2019
388
0.340
Why?
Immunotherapy, Adoptive
1
2011
156
0.330
Why?
Apoptosis
7
2024
1101
0.320
Why?
Cells, Cultured
8
2013
1573
0.320
Why?
Vascular Endothelial Growth Factor A
7
2022
201
0.320
Why?
Intercellular Adhesion Molecule-1
5
2022
63
0.320
Why?
T-Lymphocytes
1
2011
338
0.320
Why?
Structure-Activity Relationship
6
2012
395
0.320
Why?
Polyethylene Glycols
3
2021
93
0.310
Why?
Mice, Inbred C57BL
8
2021
1816
0.310
Why?
Phototherapy
2
2019
45
0.300
Why?
Amino Acid Sequence
5
2012
585
0.300
Why?
Tumor Cells, Cultured
6
2019
465
0.300
Why?
Female
24
2020
26472
0.290
Why?
Drug Resistance, Neoplasm
2
2024
308
0.290
Why?
Magnetic Resonance Spectroscopy
5
2012
244
0.280
Why?
Blood Vessels
4
2015
72
0.270
Why?
Antibodies, Monoclonal
2
2007
459
0.270
Why?
Disease Models, Animal
7
2020
1455
0.260
Why?
Molecular Sequence Data
5
2012
792
0.260
Why?
Nanoparticles
2
2017
145
0.250
Why?
Cell Division
7
2010
292
0.240
Why?
Cysteine
1
2024
50
0.240
Why?
Human Umbilical Vein Endothelial Cells
3
2014
90
0.240
Why?
Bystander Effect
1
2024
26
0.240
Why?
Buthionine Sulfoximine
1
2024
14
0.240
Why?
Nanotubes
2
2021
27
0.230
Why?
Models, Molecular
4
2024
338
0.230
Why?
Thiadiazoles
2
2024
19
0.220
Why?
Flow Cytometry
2
2017
476
0.210
Why?
Alanine
3
2012
42
0.200
Why?
Cisplatin
1
2024
278
0.200
Why?
Protein Binding
3
2012
660
0.200
Why?
Carcinoma, Renal Cell
1
2022
105
0.200
Why?
Binding Sites
2
2012
374
0.190
Why?
Optical Imaging
2
2020
25
0.190
Why?
Silver
2
2021
46
0.190
Why?
Polyurethanes
1
2021
9
0.190
Why?
Kidney Neoplasms
1
2022
177
0.190
Why?
Radiation
1
2020
15
0.190
Why?
Forkhead Transcription Factors
1
2021
112
0.190
Why?
Materials Testing
1
2021
58
0.190
Why?
Spectrum Analysis
1
2020
70
0.180
Why?
Biocompatible Materials
1
2021
69
0.180
Why?
Mice, Inbred BALB C
5
2020
304
0.180
Why?
Mice, Knockout
3
2012
841
0.180
Why?
Neoplasm Transplantation
5
2007
85
0.180
Why?
CD4-Positive T-Lymphocytes
1
2021
164
0.170
Why?
Disease Progression
3
2019
825
0.170
Why?
Oxygen Consumption
1
2020
183
0.170
Why?
Lactose
2
2024
9
0.170
Why?
Specimen Handling
1
2018
55
0.160
Why?
Spectrum Analysis, Raman
1
2019
58
0.160
Why?
Immunotherapy
1
2020
238
0.160
Why?
Drug Delivery Systems
2
2019
138
0.160
Why?
Biological Assay
1
2018
45
0.160
Why?
Time Factors
6
2017
2903
0.160
Why?
Feces
1
2018
134
0.160
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
56
0.150
Why?
Indazoles
1
2018
47
0.150
Why?
Carbohydrates
1
2018
40
0.150
Why?
Temperature
1
2018
168
0.150
Why?
Cell Hypoxia
4
2015
82
0.150
Why?
Histocompatibility Antigens Class II
1
2017
37
0.150
Why?
Tumor Microenvironment
1
2019
212
0.150
Why?
Male
9
2019
25241
0.140
Why?
Drug Therapy, Combination
1
2018
377
0.140
Why?
Neoplastic Cells, Circulating
1
2017
74
0.140
Why?
Epithelial Cells
1
2018
209
0.140
Why?
Cell Line
4
2017
1000
0.140
Why?
Lipopolysaccharides
2
2008
192
0.140
Why?
Umbilical Veins
4
2010
23
0.140
Why?
Enzyme Inhibitors
1
2018
391
0.130
Why?
Leukocytes
3
2006
66
0.130
Why?
Molecular Imaging
1
2015
53
0.130
Why?
Azides
1
2014
9
0.120
Why?
Fluorine Radioisotopes
1
2014
24
0.120
Why?
Tumor Burden
2
2013
132
0.120
Why?
Cell Transformation, Neoplastic
2
2007
177
0.120
Why?
Immunohistochemistry
5
2020
973
0.120
Why?
Interleukin-2
2
2021
72
0.120
Why?
Drug Synergism
2
2005
150
0.110
Why?
Cell Adhesion
3
2006
158
0.110
Why?
Piperacillin
1
2013
23
0.110
Why?
Peptidomimetics
1
2012
2
0.110
Why?
Penicillanic Acid
1
2013
20
0.110
Why?
Agglutination Tests
1
2012
5
0.110
Why?
Allosteric Regulation
1
2012
13
0.100
Why?
Inflammation Mediators
1
2013
112
0.100
Why?
Cell Cycle
1
2013
231
0.100
Why?
Antimicrobial Cationic Peptides
2
2008
28
0.100
Why?
Up-Regulation
2
2011
452
0.100
Why?
Partial Pressure
1
2011
14
0.100
Why?
Metformin
1
2012
64
0.100
Why?
Neoplastic Stem Cells
1
2012
103
0.090
Why?
Adjuvants, Immunologic
1
2011
51
0.090
Why?
Fibroblasts
1
2013
345
0.090
Why?
Glutamine
2
2024
171
0.090
Why?
Chemotherapy, Adjuvant
1
2011
119
0.090
Why?
Cell Movement
4
2006
247
0.090
Why?
Spiro Compounds
1
2010
8
0.090
Why?
Cytokines
1
2013
612
0.090
Why?
Lignans
1
2008
5
0.080
Why?
Salmonella typhimurium
1
2008
48
0.080
Why?
Amino Acid Substitution
1
2008
82
0.080
Why?
Klebsiella pneumoniae
1
2008
20
0.080
Why?
Furans
1
2008
26
0.080
Why?
Surface Properties
1
2007
72
0.070
Why?
Escherichia coli
1
2008
186
0.070
Why?
Angiostatins
2
2006
2
0.070
Why?
Vascular Neoplasms
1
2007
17
0.070
Why?
Endotoxins
1
2006
34
0.070
Why?
Concept Formation
1
2006
12
0.070
Why?
Gram-Negative Bacteria
1
2006
34
0.070
Why?
Protein Structure, Secondary
2
2003
72
0.070
Why?
Interleukin-8
1
2006
87
0.070
Why?
Genes, Synthetic
1
2005
1
0.070
Why?
Protein Engineering
1
2005
18
0.070
Why?
Antibodies, Monoclonal, Humanized
1
2007
225
0.060
Why?
Cloning, Molecular
1
2005
185
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
138
0.060
Why?
Angiogenic Proteins
1
2004
6
0.060
Why?
Dietary Supplements
1
2008
443
0.060
Why?
Feasibility Studies
1
2006
375
0.060
Why?
Protein Unfolding
1
2024
6
0.060
Why?
Colonic Neoplasms
1
2006
161
0.060
Why?
Disulfides
1
2024
17
0.060
Why?
Diphtheria Toxin
1
2004
4
0.060
Why?
Histones
1
2006
312
0.060
Why?
Mutagenesis, Site-Directed
1
2024
99
0.060
Why?
Protein Folding
1
2024
49
0.060
Why?
Mammary Neoplasms, Animal
1
2004
35
0.060
Why?
Osmosis
1
2003
3
0.060
Why?
Infusion Pumps
1
2003
13
0.060
Why?
Plasminogen
1
2003
2
0.060
Why?
Circular Dichroism
1
2003
41
0.060
Why?
Serum Albumin
1
2003
58
0.050
Why?
Dose-Response Relationship, Drug
2
2004
1376
0.050
Why?
Extracellular Matrix
1
2003
111
0.050
Why?
Immune Tolerance
1
2022
96
0.050
Why?
Gene Expression Regulation, Neoplastic
4
2008
828
0.050
Why?
Reactive Oxygen Species
1
2024
408
0.050
Why?
Endostatins
3
2007
4
0.050
Why?
Neoplasm Invasiveness
1
2022
267
0.050
Why?
Immunity
1
2021
35
0.050
Why?
Immune System
1
2021
44
0.050
Why?
Ethers
1
2021
8
0.050
Why?
Regenerative Medicine
1
2021
9
0.050
Why?
Melanoma
1
2004
285
0.050
Why?
Tissue Scaffolds
1
2021
33
0.050
Why?
Angiogenesis Inducing Agents
1
2000
8
0.050
Why?
Dose-Response Relationship, Radiation
1
2020
184
0.050
Why?
Tissue Engineering
1
2021
64
0.040
Why?
Adenocarcinoma
1
2004
396
0.040
Why?
Bone Marrow Cells
1
2021
191
0.040
Why?
Mice, Inbred C3H
2
2012
83
0.040
Why?
Gene Expression Profiling
1
2004
1032
0.040
Why?
Skin Neoplasms
1
2004
488
0.040
Why?
Flavin-Adenine Dinucleotide
1
2018
5
0.040
Why?
Inflammation
1
2022
604
0.040
Why?
NAD
1
2018
43
0.040
Why?
Microcirculation
2
2010
70
0.040
Why?
Guidelines as Topic
1
2018
111
0.040
Why?
Glutathione
1
2019
295
0.040
Why?
Microscopy, Fluorescence
1
2018
162
0.040
Why?
Phagocytosis
1
2017
48
0.040
Why?
Glycolysis
1
2017
70
0.040
Why?
Transplantation, Heterologous
2
2008
74
0.030
Why?
Clonal Anergy
2
2006
13
0.030
Why?
Extracellular Fluid
1
2015
15
0.030
Why?
Nitroimidazoles
1
2015
15
0.030
Why?
Microbubbles
1
2015
25
0.030
Why?
Cell Count
1
2015
147
0.030
Why?
Stromal Cells
1
2015
72
0.030
Why?
Pressure
1
2015
105
0.030
Why?
Paclitaxel
2
2006
84
0.030
Why?
Down-Regulation
2
2006
348
0.030
Why?
Drug Evaluation, Preclinical
1
2015
144
0.030
Why?
Radiochemistry
1
2014
1
0.030
Why?
Cycloaddition Reaction
1
2014
1
0.030
Why?
Click Chemistry
1
2014
2
0.030
Why?
Random Allocation
1
2015
281
0.030
Why?
Radiotherapy Dosage
1
2015
244
0.030
Why?
Imaging, Three-Dimensional
1
2015
151
0.030
Why?
Recombinant Proteins
2
2006
486
0.030
Why?
Cell Differentiation
1
2017
651
0.030
Why?
Contrast Media
1
2015
184
0.030
Why?
Molecular Structure
1
2014
297
0.030
Why?
Ultrasonography
1
2015
436
0.030
Why?
Chromatography, High Pressure Liquid
1
2014
349
0.030
Why?
Ribosomal Protein S6 Kinases
1
2012
8
0.030
Why?
Adenylate Kinase
1
2012
10
0.030
Why?
TOR Serine-Threonine Kinases
1
2012
77
0.020
Why?
Radiometry
1
2012
123
0.020
Why?
Rats
2
2008
3305
0.020
Why?
4-Butyrolactone
1
2008
5
0.020
Why?
Butylene Glycols
1
2008
14
0.020
Why?
Phytoestrogens
1
2008
22
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
51
0.020
Why?
Receptors, Progesterone
1
2008
63
0.020
Why?
Ovariectomy
1
2008
119
0.020
Why?
Estrogen Receptor beta
1
2008
54
0.020
Why?
Estrogen Receptor alpha
1
2008
89
0.020
Why?
Cell Growth Processes
1
2007
22
0.020
Why?
Carcinogens
1
2008
199
0.020
Why?
Horseshoe Crabs
1
2006
3
0.020
Why?
Blood Bactericidal Activity
1
2006
4
0.020
Why?
Lipid A
1
2006
4
0.020
Why?
Polymyxin B
1
2006
5
0.020
Why?
Neutralization Tests
1
2006
24
0.020
Why?
Cytidine
1
2006
5
0.020
Why?
Pyrroles
1
2007
69
0.020
Why?
DNA Modification Methylases
1
2006
28
0.020
Why?
Endotoxemia
1
2006
32
0.020
Why?
Acetylation
1
2006
97
0.020
Why?
Methylation
1
2006
122
0.020
Why?
Blood Proteins
1
2006
82
0.020
Why?
Chick Embryo
1
2006
82
0.020
Why?
Vimentin
1
2006
32
0.020
Why?
Nucleic Acid Hybridization
1
2006
54
0.020
Why?
Gene Silencing
1
2006
119
0.020
Why?
Cyclohexanes
1
2006
4
0.020
Why?
Zebrafish
1
2006
54
0.020
Why?
Histone Deacetylase Inhibitors
1
2006
53
0.020
Why?
Transfection
1
2007
354
0.020
Why?
Histone Deacetylases
1
2006
50
0.020
Why?
Vascular Cell Adhesion Molecule-1
1
2006
36
0.020
Why?
Pichia
1
2005
8
0.020
Why?
Gene Transfer Techniques
1
2005
37
0.020
Why?
Cyclophosphamide
1
2006
165
0.020
Why?
Neovascularization, Physiologic
1
2005
68
0.020
Why?
Sequence Homology, Nucleic Acid
1
2004
48
0.020
Why?
Membrane Proteins
1
2006
341
0.010
Why?
Indoles
1
2007
278
0.010
Why?
Treatment Outcome
1
2014
5141
0.010
Why?
Necrosis
1
2004
176
0.010
Why?
Antibodies
1
2004
154
0.010
Why?
Skin
1
2007
409
0.010
Why?
In Situ Nick-End Labeling
1
2003
57
0.010
Why?
Base Sequence
1
2004
643
0.010
Why?
Sequence Homology, Amino Acid
1
2003
144
0.010
Why?
Epigenesis, Genetic
1
2006
374
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
595
0.010
Why?
Mice, Transgenic
1
2004
555
0.010
Why?
RNA, Messenger
1
2004
1105
0.010
Why?
Endothelial Growth Factors
1
2000
9
0.010
Why?
Vascular Endothelial Growth Factors
1
2000
15
0.010
Why?
Fibroblast Growth Factor 2
1
2000
34
0.010
Why?
Lymphokines
1
2000
20
0.010
Why?
Scrotum
1
2000
30
0.010
Why?
Interleukin-1
1
2000
104
0.010
Why?
Models, Biological
1
2002
727
0.010
Why?
Breast Neoplasms
1
2004
1174
0.010
Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description